Spectrum Pharma (SPPI) Posts Weaker Q1 Results
Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI) reports Q1 loss of $0.80, versus the analyst estimate of ($0.15). Revenue for the quarter was $11.1 million, which compares to the estimate of $9.88 million.
You May Also Be Interested In
- Netflix (NFLX) Director Jay Hoag Scoops Up 600,000 Shares
- Power Integrations (POWI) Tops Q2 EPS by 9c
- Weingarten Realty Investors (WRI) Tops Q2 FFO by 1c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!